Search | Webyourself Social Media Platform

Dhanashri Patil eine Datei hinzugefügt Health
2024-03-26 12:47:23 -

Advancing Precision Oncology: Exploring Biomarkers For PARP Inhibitor Therapy In Cancer Treatment
Precision medicine aims to match the right treatment to the right patient based on the molecular characteristics of their cancer. PARP inhibitors are one type of targeted therapy that has shown promise in certain breast and ovarian cancers linked to defective DNA repair pathways. However, identifying predictive biomarkers remains an active area of research to optimize patient selection and...

0 Kommentare 0 Geteilt 1715 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Pooja Salve eine Datei hinzugefügt Health
2023-09-20 11:20:40 -

Global PARP Inhibitor Biomarkers Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Cancer & Rising Demand for Personalized Medicine
The Global PARP Inhibitor Biomarkers Market is estimated to be valued at US$ 907.1 million in 2023 and is expected to exhibit a CAGR of 24.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The PARP Inhibitor Biomarkers market is experiencing significant growth due to the increasing incidence of cancer worldwide. PARP...

0 Kommentare 0 Geteilt 1782 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Poojacmi Salve eine Datei hinzugefügt Health
2023-08-18 06:44:51 -

Global PARP Inhibitor Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Cancer and Rising Geriatric Population
The global PARP Inhibitor Market is estimated to be valued at USD 6.60 billion in 2022 and is expected to exhibit a CAGR of 13.09% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:PARP inhibitors are a class of drugs that inhibit the activity of Poly (ADP-ribose) polymerase (PARP) enzymes in the body. These enzymes play...

0 Kommentare 0 Geteilt 2511 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Ashwini Bakhade eine Datei hinzugefügt Andere
2024-02-22 11:47:21 -

PARP Inhibitor Biomarkers - The Key to Precision Cancer Treatment
Precision oncology has revolutionized cancer treatment in recent years with the introduction of targeted therapies that rely on identifying specific biomarkers. Poly ADP-ribose polymerase or PARP inhibitors are a class of targeted drugs that have shown great promise in certain cancers associated with DNA repair deficiencies. However, like other targeted therapies, identifying the right patients...

0 Kommentare 0 Geteilt 1197 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Raj Kumar Dhote eine Datei hinzugefügt Health
2023-12-27 13:05:47 -

PARP Inhibitor Biomarkers Market Are Estimated To Witness High Growth Owing To Rising Demand As Companion Diagnostics
PARP (Poly ADP-Ribose Polymerase) inhibitor biomarkers are used for the stratification of patients with certain cancers like breast and ovarian cancer into those likely to respond to PARP inhibitor treatment and those unlikely to respond. They play an important role as companion diagnostics alongside PARP inhibitors drugs to identify patients with homologous recombination deficiency (HRD)...

0 Kommentare 0 Geteilt 1236 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Naufan Cmi eine Datei hinzugefügt Andere
2024-02-27 12:27:15 -

PARP Inhibitor Biomarkers Market is Anticipated to Witness High Growth Owing to Increased Adoption of Precision Medicine
PARP inhibitor biomarkers are essential diagnostic tools for cancer treatment and identifying response rates to PARP inhibitor therapies. PARP inhibitors are increasingly used for the treatment of metastatic cancers with BRCA mutations. These inhibitors are primarily used for treating cancers like ovarian, breast, and prostate cancers. Rising cancer prevalence worldwide drives the adoption of...

0 Kommentare 0 Geteilt 1065 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Pratik Chopade eine Datei hinzugefügt Health
2024-05-30 07:20:46 -

PARP Inhibitor Biomarkers Market Is Driven By Increasing Prevalence Of Cancer
The PARP inhibitor biomarkers market involves the use of biomarkers to detect PARP inhibitors which are a class of targeted therapy approved for the treatment of cancers like ovarian cancer and breast cancer. PARP inhibitors work by blocking an enzyme called poly (ADP-ribose) polymerase or PARP which is involved in DNA repair. When PARP is blocked, DNA damage caused by chemotherapy or radiation...

0 Kommentare 0 Geteilt 652 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Pooja Salve eine Datei hinzugefügt Health
2024-01-03 11:07:23 -

PARP Inhibitor Market is Estimated to Witness High Growth Owing to Increasing Adoption in Oncology Treatment
Market Dynamics Increasing adoption in oncology treatment: The key driver for the growth of the PARP inhibitor market is its increasing adoption in the treatment of various cancers like breast and ovarian cancers. As per the National Cancer Institute, PARP inhibitors have shown promising results in slowing or stopping the growth of cancer cells with BRCA1 or BRCA2 gene mutations. This is...

0 Kommentare 0 Geteilt 1217 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Sneha CMI eine Datei hinzugefügt Andere
2024-01-04 12:27:34 -

Rising Incidences of Cancer of PARP Inhibitor Market
The global PARP Inhibitor Market is estimated to be valued at US$ 6.13 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. SWOT Analysis Strength: Parp inhibitor drugs have shown promising results in clinical trials for breast cancer and ovarian cancer...

0 Kommentare 0 Geteilt 2351 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Purvaja Jadhao eine Datei hinzugefügt Andere
2023-11-09 09:46:30 -

Rising Prevalence of Cancer Drives Growth of the PARP Inhibitor Market
Market Overview:The PARP Inhibitor Market is estimated to be valued at US$887.7 million in 2023 and is projected to reach US$ 19.37 billion in 2030. PARP inhibitors are a class of drugs that target poly (ADP-ribose) polymerase (PARP) enzymes involved in DNA repair processes. These inhibitors have shown promising results in the treatment of cancers, particularly in patients with BRCA1 and BRCA2...

0 Kommentare 0 Geteilt 1440 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
Samruddhi Bhujade eine Datei hinzugefügt Andere
2023-12-15 13:50:42 -

PARP Inhibitors Market To Witness High Growth Due To Increasing Adoption In Cancer Treatment
PARP inhibitors are a type of targeted therapy used to treat certain cancers, including ovarian cancer, breast cancer and prostate cancer. They work by blocking an enzyme called poly (ADP-ribose) polymerase (PARP), which helps repair DNA damage in cells. When PARP is blocked, DNA damage isn't repaired properly and cancer cells cannot survive and eventually die. PARP inhibitors are primarily...

0 Kommentare 0 Geteilt 1271 Ansichten 0 Bewertungen

Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!

Mehr Ergebnisse